Beckman Coulter Subsidiary Agencourt Bioscience Enters Into Supply Agreement With Affymetrix
November 29 2005 - 8:30AM
PR Newswire (US)
Agencourt(R) RNAClean(TM) Nucleic Acid Purification Product for
cDNA and cRNA Purification to be Part of Affymetrix Reagent Product
Line FULLERTON, Calif., Nov. 29 /PRNewswire-FirstCall/ -- Agencourt
Bioscience Corporation, a wholly owned subsidiary of Beckman
Coulter (NYSE:BEC), today announced the signing of a distribution
and supply agreement with Affymetrix Inc. (NASDAQ:AFFX). Agencourt
will provide a nucleic acid purification product, Agencourt
RNAClean, to be included in the reagent kit for Affymetrix'
GeneChip(R) Array Station, an automated target preparation and
microarray processing system that reduces labor and improves the
standardization of experimental results. (Logo:
http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) Agencourt
RNAClean provides a simple, highly reproducible method for
preparing quality nucleic acids for use in applications such as
microarray analysis. Agencourt RNAClean enables the researcher to
use one product to complete both cDNA and cRNA purification steps.
Affymetrix will incorporate the SPRI magnetic bead technology into
the automated GeneChip Array Station reagent product offering. "We
are pleased that Affymetrix has selected our product for cDNA and
cRNA cleanup in support of their GeneChip Array Station," stated
Lynn Doucette- Stamm, Ph.D., Agencourt's vice president business
development. "Beta site testing of this product for use with
systems installed by Affymetrix has been outstanding, and we look
forward to continued growth of the product line." "The integration
of the SPRI technology and specifically the Agencourt RNAClean
product allows us to provide our customers with an optimal
automated target preparation solution for their GeneChip microarray
experiments," said Alan Dance, senior vice president of business
development at Affymetrix. "By improving data consistency and
decreasing the hands-on time needed to perform experiments, the
Affymetrix Array Station enables scientists to accelerate
discovery, publication, and bring new tests and therapies to market
more quickly." Agencourt Bioscience Corporation, a wholly owned
subsidiary of Beckman Coulter, Inc., is a leading provider of
genomic services and nucleic acid purification products in the life
sciences market. Our products and services support the advancement
of science in understanding biology, improving health and
delivering safe and effective treatments for disease. Agencourt's
purification products and services are based on the proven and
patented Solid Phase Reversible Immobilization (SPRI) technology,
which has been adopted by several of the largest genome research
facilities and used to sequence over one-third of the human genome.
Agencourt is one of five NHGRI-funded Large- Scale Sequencing
Centers whose goal is to sequence genomes of organisms of high
biomedical importance. The company's state-of-the-art facilities
are guided by the FDA's Good Laboratory Practices (GLP) as a
contract analytical laboratory. Agencourt is located in Beverly,
Massachusetts. For more information about Agencourt Bioscience
visit our website at http://www.agencourt.com/. Affymetrix
scientists invented the world's first high-density microarray in
1989 and began selling the first commercial microarray in 1994.
Since then, Affymetrix GeneChip(R) technology has become the
industry standard in molecular biology research. Affymetrix
technology is used by the world's top pharmaceutical, diagnostic
and biotechnology companies as well as leading academic, government
and not-for-profit research institutes. More than 1,300 systems
have been installed around the world and nearly 3,000 peer-reviewed
papers have been published using the technology. Affymetrix'
patented photolithographic manufacturing process provides the most
information capacity available today on an array, enabling
researchers to use a whole-genome approach to analyzing the
relationship between genetics and health. Affymetrix is
headquartered in Santa Clara, Calif., with manufacturing facilities
in Sacramento, Calif., and Bedford, Mass. The company maintains
important sales and marketing operations in Europe and Asia and has
about 1,000 employees worldwide. For more information about
Affymetrix, please visit the company's website at
http://www.affymetrix.com/. Beckman Coulter, Inc. is a leading
manufacturer of biomedical testing instrument systems, tests and
supplies that simplify and automate laboratory processes. Spanning
the biomedical testing continuum -- from pioneering medical
research and clinical trials to laboratory diagnostics and
point-of- care testing -- Beckman Coulter's 200,000 installed
systems provide essential biomedical information to enhance health
care around the world. The company, based in Fullerton, Calif.,
reported 2004 annual sales of $2.4 billion with 64 percent of this
amount generated by recurring revenue from supplies, test kits and
services. For more information, visit
http://www.beckmancoulter.com/. Contacts: Beckman Coulter
Affymetrix Jeanie Herbert Doug Farrell (714) 773-7620 (408)
731-5285 Investor Relations Investor Relations Anne M. Warde Wes
Conard (714) 773-7655 (408) 731-5791 Media Relations Public
Relations http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO
http://photoarchive.ap.org/ DATASOURCE: Beckman Coulter CONTACT:
Investor Relations, Jeanie Herbert, +1-714-773-7620, or Media
Relations, Anne M. Warde, +1-714-773-7655, both of Beckman Coulter;
or Investor Relations, Doug Farrell, +1-408-731-5285, or Public
Relations, Wes Conard, +1-408-731-5791, both of Affymetrix Web
site: http://www.beckmancoulter.com/ http://www.agencourt.com/
http://www.affymetrix.com/
Copyright
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024